The Hindu29d
Biosimilars and the need for a policy prescription
To understand the class of drugs known as biosimilars, it is first necessary to understand the class of drugs described as biologics. Traditionally, biologics were derived through natural ...
Business Wire14d
Xevant Introduces the All-New Biosimilar Dashboard, A Real-Time Analytics Tool to Accelerate Biosimilar Adoption and Reduce Unnecessary Biologic Drug Spend
Specialty drugs now account for 51% of total prescription spending, and this figure is expected to rise by 8% through 2025. Meanwhile, biosimilars present a potential $54 billion in savings over ...